documents: FDA-2026-N-3962-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-3962-0001 | FDA | FDA-2026-N-3962 | Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments— United States (U.S.) 2026–2027 Formula for COVID–19 Vaccine Composition | Notice | Request for Comments | 2026-04-27 | 2026 | 4 | 2026-04-27 | 2026-05-28 | 2026-05-17 09:00:24 | 2026-08122 | 1 | 0 | 09000064b92ad21d |